Cargando…
Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
BACKGROUND: Avascular necrosis is a common organ damage in SLE patients, which can influence patients’ life quality. Conflicting results exist in risk factors of AVN in SLE patients. The aim of this study was to illustrate risk factors predicting the occurrence of avascular necrosis (AVN), also know...
Autores principales: | Cheng, Cheng, Huang, Can, Chen, Zhen, Zhan, Feng, Duan, Xinwang, Wang, Yongfu, Zhao, Cheng, Wu, Zhenbiao, Xu, Jian, Li, Hongbin, Yang, Min, Wu, Rui, Zhao, Jiuliang, Zhang, Shangzhu, Wang, Qian, Leng, Xiaomei, Tian, Xinping, Li, Mengtao, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176939/ https://www.ncbi.nlm.nih.gov/pubmed/37173771 http://dx.doi.org/10.1186/s13075-023-03061-3 |
Ejemplares similares
-
Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
por: Xiang, Yirong, et al.
Publicado: (2021) -
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
por: Gui, Yinli, et al.
Publicado: (2022) -
Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus
por: Shi, Yue, et al.
Publicado: (2022) -
Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021) -
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)